Jennifer Straumins Sells 100,000 Shares of Calumet, Inc. (NASDAQ:CLMT) Stock

Calumet, Inc. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 100,000 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $16.23, for a total transaction of $1,623,000.00. Following the sale, the director now directly owns 934,589 shares of the company's stock, valued at $15,168,379.47. This represents a 9.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Jennifer Straumins also recently made the following trade(s):

• On Friday, June 13th, Jennifer Straumins sold 50,000 shares of Calumet stock. The shares were sold at an average price of $15.08, for a total value of $754,000.00.
• On Thursday, June 5th, Jennifer Straumins sold 100,000 shares of Calumet stock. The stock was sold at an average price of $13.17, for a total value of $1,317,000.00.

Calumet Stock Performance

NASDAQ:CLMT traded down $0.06 during midday trading on Friday, reaching $16.37. 1,463,834 shares of the stock traded hands, compared to its average volume of 967,974. The business has a 50-day moving average of $12.65 and a two-hundred day moving average of $15.21. Calumet, Inc. has a 12-month low of $7.68 and a 12-month high of $25.29. The stock has a market capitalization of $1.41 billion, a PE ratio of -4.09 and a beta of 0.91.

Calumet (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The firm had revenue of $993.90 million during the quarter, compared to analysts' expectations of $899.62 million. Calumet's quarterly revenue was down 1.2% on a year-over-year basis. During the same period last year, the firm earned ($0.51) earnings per share. Research analysts anticipate that Calumet, Inc. will post -3.02 earnings per share for the current year.

Wall Street Analyst Weigh In

CLMT has been the topic of a number of recent research reports. Bank of America began coverage on Calumet in a research report on Tuesday, May 13th. They set a "buy" rating and a $15.00 price target on the stock. TD Cowen lowered shares of Calumet from a "buy" rating to a "hold" rating and reduced their price target for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. HC Wainwright reaffirmed a "buy" rating and issued a $33.00 price target on shares of Calumet in a research report on Monday, March 3rd. Wells Fargo & Company cut their price objective on shares of Calumet from $23.00 to $21.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Finally, The Goldman Sachs Group lowered their target price on Calumet from $16.00 to $14.00 and set a "buy" rating for the company in a report on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $18.50.

Calumet Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.